Abstract
The current recommendation is unless an individual is at high risk for influenza complication, to not start anti-influenza medication if delayed more than 48 hours after onset of symptoms [1-3]. This recommendation was the result of clinical investigation design and data submitted to the FDA for licensure, routine shortages of influenza medications and a concern of evolving antiviral resistance.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
